Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Malignancies

Clinical trial condition

Hematologic Malignancies

Explore clinical trials studying Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

134 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Malignancies trial results

Completed

A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04696809

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Kameda Medical Center Chiba, Japan

Ogaki Municipal Hospital Gifu, Japan

National Hospital Organization Mito Medical Center Higashiibaraki-gun, Japan

Kobe City Medical Center General Hospital Kobe, Japan

View all 15 locations

View Trial Details

Completed

A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

NCT02494258

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasm, +4 more
Locations: Local Institution - 101 Gainesville, Florida, United States

Local Institution - 103 Baltimore, Maryland, United States

Local Institution - 102 Houston, Texas, United States

Manchester Royal Infirmary Manchester, United Kingdom

View Trial Details

Completed

An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

NCT05433090

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China

NCT06900114

Conditions: Bacterial Infections and Mycoses, COVID-19, Coronaviridae Infections, +19 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Completed

Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies

NCT05371054

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

NCT01203722

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

NCT07200583

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Graft Failure, Hematologic Diseases, +6 more
Locations: The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350001 Fuzhou, Fujian, China

View Trial Details

Completed

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

NCT04112810

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations: Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

NCT02988466

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Failure Disorders, +53 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

NCT00429143

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details